[go: up one dir, main page]

AU6979594A - Compositions and methods for treatment and prevention of retinal dysfunctions - Google Patents

Compositions and methods for treatment and prevention of retinal dysfunctions

Info

Publication number
AU6979594A
AU6979594A AU69795/94A AU6979594A AU6979594A AU 6979594 A AU6979594 A AU 6979594A AU 69795/94 A AU69795/94 A AU 69795/94A AU 6979594 A AU6979594 A AU 6979594A AU 6979594 A AU6979594 A AU 6979594A
Authority
AU
Australia
Prior art keywords
prevention
compositions
treatment
methods
dysfunctions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU69795/94A
Inventor
Vladimir Khatskelevich Khavinson
Andrey Leonidovich Kozhemyakin
Sergey Vladimirovich Sery
Rustem Ilyasovich Valeyev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEOPHARM Ltd
Original Assignee
NEOPHARM Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEOPHARM Ltd filed Critical NEOPHARM Ltd
Publication of AU6979594A publication Critical patent/AU6979594A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU69795/94A 1993-06-17 1994-06-17 Compositions and methods for treatment and prevention of retinal dysfunctions Withdrawn AU6979594A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU93030389A RU2073518C1 (en) 1993-06-17 1993-06-17 Agent recovering retina eye function
RO93030389 1993-06-17
PCT/IB1994/000192 WO1995000156A1 (en) 1993-06-17 1994-06-17 Compositions and methods for treatment and prevention of retinal dysfunctions

Publications (1)

Publication Number Publication Date
AU6979594A true AU6979594A (en) 1995-01-17

Family

ID=20142934

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69795/94A Withdrawn AU6979594A (en) 1993-06-17 1994-06-17 Compositions and methods for treatment and prevention of retinal dysfunctions

Country Status (3)

Country Link
AU (1) AU6979594A (en)
RU (1) RU2073518C1 (en)
WO (1) WO1995000156A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803931B2 (en) 2004-02-12 2010-09-28 Archemix Corp. Aptamer therapeutics useful in the treatment of complement-related disorders
KR101513308B1 (en) * 2006-03-08 2015-04-28 아케믹스 엘엘씨 Complement-aptamers and anti-C5 agents useful for the treatment of ocular diseases
RU2301072C1 (en) * 2006-06-22 2007-06-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Agent for normalizing of blood-vessel function and method for production thereof
RU2558976C2 (en) * 2013-09-19 2015-08-10 Венера Айратовна Шаимова Method of predicting development of vitreoretinal traction in case of peripheral retinal degeneration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117057C3 (en) * 1971-04-07 1980-07-31 Biofarm Fabrica De Medicamente, Bukarest (Rumaenien) Process for the manufacture of a medicament for the treatment of eye diseases
IT1219839B (en) * 1988-02-08 1990-05-24 Fidia Farmaceutici PURIFICATION, CHARACTERIZATION AND APPLICATION OF A NEURONOTROPHIC FACTOR DERIVED FROM NAMMIFEROUS BRAIN
IT1219874B (en) * 1988-03-18 1990-05-24 Fidia Farmaceutici USE OF THE HUMAN NERVE GROWTH FACTOR AND ITS PHARMACEUTICAL COMPOSITIONS
US5166317A (en) * 1988-10-31 1992-11-24 Houston Biotechnology Incorporated Neurotrophic factor

Also Published As

Publication number Publication date
RU2073518C1 (en) 1997-02-20
WO1995000156A1 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
AU3691793A (en) Gas well treatment compositions and methods
AU3519893A (en) Antitumor compositions and methods of treatment
AU4214193A (en) Bioadhesive treatment compositions and method of use
AU4861493A (en) Clear leave-on treatment composition and method
AU5439996A (en) Compositions and methods for treating pain
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU4032989A (en) Method and compositions for the treatment and prevention of septic shock
AU2113295A (en) Novel compositions and methods for water treatment
AU8044491A (en) Antitumor compositions and methods of treatment
AU3681095A (en) Method and pharmaceutical composition for prevention and treatment of brain damage
AU2180097A (en) Composition for prevention and treatment of periodontal diseases
AU2821295A (en) Compositions and methods for the treatment of tumors
AU5631096A (en) Antihistamine-wound healing compositions and methods for pre paring and using same
AU3965497A (en) Methods of treatment of eye trauma and disorders
AU8192691A (en) Method of treatment and compositions therefore
GB2294637B (en) Therapeutic compositions and methods of use
AU2843397A (en) Agent for prophylaxis and treatment of disturbance of visual function
AU6979594A (en) Compositions and methods for treatment and prevention of retinal dysfunctions
AU4104093A (en) Method and compositions for treatment of pyonecrotic processes
AU5293293A (en) Methods and compositions for treatment of allergic disease
AU2750297A (en) Methods for prevention and/or treatment of neutropenia
AU4604697A (en) Compositions and methods for the treatment of human cytomegalovirus infection
AU3555793A (en) Pharmaceutical compositions for the treatment and/or prevention of degenerative disorders in the retina
AU1240295A (en) Pharmaceutical composition for immunomodulating and adjuvant treatment
AU5446798A (en) Compositions and methods for the treatment of gastrointestinal disorders